• Greetings from the CTSA Coordination, Communication, and Operations Support (CCOS) Center! In this transition update, we’ll be introducing our 6th and final team – Technical Development. This team is led by Monikka Ravichandran, MS, a software developer with years of experience in designing, developing, and delivering software to achieve optimal user experiences. Creating and launching our new
  • The award was presented at Research! America’s 27th Advocacy Awards held at the National Academy of Sciences in Washington, D.C. on March 15, 2023. Dr. Pamela Davis has been recognized by the Board of Directors of Research! America for a career of distinguished leadership and sustained commitment to public engagement and advocacy for research. Dr. Davis was founding PI of the Clinical and
  • We get a lot of questions about CTSC membership and what it means. While we often refer to those who join us in our mission as 'members,' there is no application or vetting process. You become a member simply by using our resources or taking part in CTSC activities. Our goal is to make our resources widely available and share our knowledge and expertise with anyone interested in improving clinical
  • National Institutes of Health
    National Institutes of Health
    Rare Disease Day®(link is external) takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. Since 2011, NCATS and the NIH Clinical Center have sponsored Rare Disease Day at NIH as part of this global observance. Rare Disease Day at NIH aims to raise awareness about
  • The NCATS-funded Evolve to Next-Gen ACT (ENACT) is a collaborative research platform that will enable investigators at CTSA hubs to conduct EHR research on any disease or condition from their desktop. Using de-identified data from EHRs for >142 million patients at 57 hubs, ENACT will also allow data scientists to develop and test EHR-based research tools. ENACT is the next iteration of the ACT

  • NCATS collaborate innovate celebrate
    Registration is now open for the Assay Guidance Workshop for High-Throughput Screening and Lead Discovery that will be held in-person on October 18-19, 2022 at the Porter Neuroscience Research Center (Building 35A), NIH Main Campus, Bethesda, MD. This event is free to register. This workshop includes speakers from pharma, biotech, government and academia. Presentations cover a wide range of topics
  • The SC Clinical and Translational Science Institute (SC CTSI) at the University of Southern California (USC) and Children’s Hospital Los Angeles (CHLA) is planning a broad range of projects to support and improve clinical and translational research through renewal of a Clinical and Translational Science Award from the National Center for Advancing Translational Science in the U. S. National

  • Slide with headshots of CLIC MPIs, Martin Zand, MD, PhD, and Debbie Ossip, PhD
    Researchers across the country gathered virtually earlier this month to dive into the ever growing pool of big data at the two-day Un-Meeting event, “Making Real-World Data and Real-World Evidence a Reality for Translational Science.”
  • Omni Hotel
    Meeting Theme: Achieving Health Equity through the Science of Translation
  • blue color with honeycomb design in the bottom left corner featuring icons

    NCATS Rapid Response Un-Meeting

    Moving scientific discoveries into the “real world” effectively, efficiently, and safely are core principles of translational science. With the advent of big data analytics and data derived from multiple sources, it has become increasingly clear that utilizing data from real-world contexts opens another key layer of the translational science process.

  • Headshots of Hua Xu, Frank Manion, and Pablo Cure
    Join NCATS SBIR/STTR and CTSA awardee company Melax Tech for a panel discussion hosted by Lili Portilla, M.P.A. Learn how Melax Tech successfully leveraged the SBIR grant in the development of their natural language processing technology with additional support from the CTSA program.
  • The University of Pennsylvania will be conducting a mixed methods study, funded by NCATS through a bioethics supplement to the University of Pennsylvania’s CTSA, to examine institutional approaches to prioritizing COVID-19 trials. The goal of this study is to understand relevant processes and criteria applied during the pandemic, as well as perspectives on potentially extending these approaches to
  • NIH Banner announcing Behavioral and Social Science Research Festival November 18th and 19th from 1pm to 4:30pm EST
    National Institutes of Health
    Join the NIH Office of Behavioral and Social Sciences Research (OBSSR) virtually on Thursday, November 18 and Friday, November 19, from 1:00 p.m. to 4:30 p.m. EST each day, for the annual NIH Behavioral and Social Sciences Research (BSSR) Festival. Register to attend and view the festival agenda and speaker biographies: The festival, hosted by
  • NCATS collaborate innovate celebrate
    Virginia Commonwealth University
    Are you a research entrepreneur or small business focused on translational science? Join the VCU Wright Center for Clinical and Translational Research and Innovation Gateway in collaboration with the National Center for Advancing Translational Sciences for a webinar on small business funding opportunities. Learn more about non-dilutive Small Business Innovation Research and Small Business
  • The NCATS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help foster small business participation in research and development as well as technology commercialization. These programs are engines of innovation, offering grants, contracts and technical assistance to small businesses and academic research organizations. There are many benefits to

  • With proper business development tools and insights into entrepreneurship, biomedical researchers can improve the potential of their discoveries in the laboratory reaching patients. I-Corps@NCATS, a University of Miami (UM) Clinical and Translational Science Institute (CTSI) program, helps entrepreneurial-minded researchers move their new drugs, diagnostics, technologies, and devices forward to the next stage of development.
  • NCATS recently solicited feedback on the NCATS CTSA Program from the stakeholder community through a variety of mechanisms, including through a 2019 public Request for Information (NOT-TR-19-027) and general feedback from CTSA application peer reviewers (video). The most recent comments and questions were received in response to the presentation and discussion of the CTSA Program Funding
  • Clinical and Translational Science

    The mission of translational science is to bring predictivity and efficiency to the development and dissemination of interventions that improve human health. Ten years ago this year, the National Center for Advancing Translational Sciences was founded to embody, conduct, and support this new discipline.

  • City Scape with lines and orbs above locations implying people connecting to a virtual network
    Meeting Theme: Intentional Disruption and Innovation: The Future of Translational Science Objective: To highlight changes and innovations that CTSA Program consortium hubs had to make during the COVID pandemic; describing the creative innovations developed and what they suggest concerning intentionally causing the disruption and spurring innovative solutions in the post-COVID world.
  • Zoom screenshot of Dr. Elizabeth Ofili, a principal investigator at the Georgia CTSA, giving a 4x4 presentation at the Un-Meeting.
    Dr. Elizabeth Ofili, a principal investigator at the Georgia CTSA, gives a 4x4 presentation at the Un-Meeting. Researchers across the country gathered virtually last month to discuss outreach to community hospitals for recruitment and enrollment into clinical trials at the CLIC-hosted Un-Meeting “Exploring the Inclusion of Community Hospitals in Clinical Research.” The topic, chosen by the
  • We all know the importance of branding. For your reference, this guide contains brand-approved color palettes, typography, imagery and more.

  • University Of Southern California

    Manuscript appearing in the Journal of Clinical and Translational Science, published online April 20, 2021.

  • Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID 19 Therapeutic
  • For victims of sexual assault, high-quality health care provided by sexual assault nurse examiners (SANEs) is associated with improved health and prosecutorial outcomes. However, very little is known about access to SANEs. Sheridan Miyamoto, assistant professor and SAFE-T Center principal investigator, and Elizabeth Thiede, nursing doctoral student and 2021 ENRS Student Conference Scholarship
  • The Translational Science Interagency Fellowship (TSIF) program is jointly sponsored by NCATS and the U.S. Food and Drug Administration (FDA) and aims to provide training in both translational science and regulatory science. The common goal of NCATS and the FDA is to bring safe and effective drugs, regimens and devices from the bench to the bedside as quickly and efficiently as possible. To that

  • I-Corps Regional Short Course
    University Of California Davis
    Based on the National Science Foundation’s Innovation Corps (I-Corps™) program, the premier federally-funded innovation and commercialization training in the U.S., I-Corps@NCATS provides biomedical scientists, clinician scientists, and engineers with a new approach to accelerate the translation of discoveries from the lab to clinical practice. WHO: Teams of faculty, postdocs, and/or students with
  • The Translational Science Interagency Fellowship (TSIF) is a new postdoctoral fellowship opportunity developed by the National Center for Advancing Translational Sciences (NCATS) and the U.S. Food and Drug Administration (FDA). Fellows will be jointly mentored by NCATS and FDA scientists on a research project of mutual interest to both organizations. Fellows in this program will develop skills of

  • The Center for Clinical & Translational Science will use new grant to help grow the reach of I-Corps@NCATS in order to help scientists translate their discoveries to the marketplace.

  • Researchers at the University of Arkansas for Medical Sciences (UAMS) will use a $228,000 federal grant to test telehealth as a way to improve Arkansas’ death rate among pregnant women, which ranks fifth nationally. Led by UAMS’ Hari Eswaran, Ph.D., the research team will focus on remote health monitoring of pregnant women in rural areas with few health providers or resources. The goal is to

  • Medical diagnoses involving alcohol-related disorders, substance-related disorders and suicidal thoughts and behaviors – commonly referred to as diseases of despair – increased in Pennsylvania health insurance claims between the years 2007 and 2018, according to researchers from Penn State Clinical and Translational Science Institute and Highmark Health Enterprise Analytics. Princeton economists